早期低剂量新鲜冰冻血浆在烧伤复苏中的安全性与有效性
结果显示输注后3小时尿量和输入/输出比显著改善,且未发生复苏相关并发症。
要点
- 伤后中位7小时开始输注新鲜冰冻血浆,中位输注量1517 mL。
- 输注后3小时尿量从0.19升至0.52 mL/kg/h,输入/输出比从0.8降至0.4。
- 未发生腹腔间隔室综合征、急性呼吸窘迫综合征或输血反应等并发症。
核心结论
- 在烧伤复苏中加入低剂量标准化新鲜冰冻血浆输注可显著改善尿量并使输入/输出比正常化,且未导致已知并发症。
主要发现
- 患者以男性为主(85%),中位年龄36岁,中位TBSA烧伤39%(范围24.5%-94%)。
- 伤后中位7小时开始输注新鲜冰冻血浆,中位输注量1517 mL。
- 中位输入/输出比从新鲜冰冻血浆开始时0.8改善至输注后3小时0.4,P < .001。
- 中位尿量从新鲜冰冻血浆输注前0.19 mL/kg/h改善至输注后3小时0.52 mL/kg/h,P < .001。
- 未发生腹腔间隔室综合征、急性呼吸窘迫综合征或输血反应等复苏相关并发症。
关键数值与推荐
- 新鲜冰冻血浆以8小时、0.5 mL/kg/%TBSA的非滴定式输注方式加入烧伤复苏。
临床怎么用
- 可考虑在成年>20%TBSA烧伤患者的护理驱动复苏方案中早期加入标准化低剂量新鲜冰冻血浆输注,以改善尿量和输入/输出比。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Growing evidence supports the addition of fresh frozen plasma (FFP) to a standardized crystalloid-based burn resuscitation. Fresh frozen plasma is thought to mitigate endotheliopathy, decrease total fluids and improve outcomes; however, when and how much FFP to give remains controversial. Here, we assessed the safety and efficacy of adding a non-titratable, 8-hr FFP infusion of 0.5 mL/kg/% total body surface area (TBSA) to a burn resuscitation. We performed an unmatched retrospective cohort review on all patients with burn injuries aged > 18 years old with > 20% TBSA burns who underwent our nursing-driven resuscitation protocol that included this early, standardized FFP infusion, from November 2016 to May 2020. Fifty-three patients received FFP and met inclusion criteria. Patients were primarily male (85%), with a median age of 36 years and a TBSA burn of 39% (range 24.5%-94%). Median time to FFP administration was 7 h from injury with a median of 1517 mL infused. Median input/output (I/O) ratio improved from 0.8 at FFP initiation to 0.4 at 3 h post-FFP, P < .001. Median urine output (UOP) improved from 0.19 mL/kg/h prior to FFP administration to 0.52 mL/kg/h at 3 h post-FFP, P < .001. No complications related to resuscitation such as abdominal compartment syndrome, acute respiratory distress syndrome, or transfusion reactions occurred. Therefore, adding a low-dose, standardized FFP infusion to burn resuscitations significantly improved UOP, normalized I/O ratios, and did not cause any known complications. Standardizing a safe, effective, non-titratable FFP infusion provides the framework to systematically test how colloids can be optimized during burn resuscitations in the future.
引用
- Wiktor AJ, Vogler TO, Carmichael H, et al. Safety and Efficacy of an Early Low-Dose Fresh Frozen Plasma Infusion in Burn Resuscitation. J Burn Care Res. 2026. PMID: 41466517. doi:10.1093/jbcr/iraf233
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。